PERSPECTIVE OF INNOVATION DRUG FORMULATION WITH DARUNAVIR ETHANOLAT
Article shows the results of development and technological issues of darunavir ethanolate in capsule form. Soluplus was used to increase the biopharmaceutical characteristics of current drug formulation. Results of dissolution profile studies shows that intensity and release rate of API from the cap...
Saved in:
Main Authors: | S. A. Zolotov, N. B. Diomina, G. F. Vasilenko, M. S. Demin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/155 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation and release testing of mecobalamin in gelatin capsule derived from striped Snakehead (Channa striata)
by: Mayang Sari Nurman, et al.
Published: (2025-07-01) -
<i>In-vitro</i> dissolution profiles comparison for various drugs with active ingredient Febuxostat commercially available on the Russian market
by: S. V. Denkina, et al.
Published: (2024-01-01) -
Vitamin D drug formulation: from active substance to therapeutic effects
by: A. S. Dukhanin
Published: (2022-10-01) -
Design and Flow Field Analysis of Extendable Leaching-optimized Cavern Construction Device for Salt Cavern Gas Storage
by: C. Zha, et al.
Published: (2025-07-01) -
On the history of VIR foundation
by: V. K. Shumny, et al.
Published: (2019-10-01)